Matthew Shields, EVP, Global Operations at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 34,590 shares at $31.67 ($1.1M) on 2026-03-05, disclosed to the SEC on 2026-03-09.
Open-market sale of $1.1M TEVA by EVP, Global Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.67 | 17,295 | $548K | 50.0% |
| 2 | $31.67 | 17,295 | $548K | 50.0% |
| Total | $31.67 avg | 34,590 | $1.1M | 100% |
| Filing → |
| TEVA | SELL | 2025-06-05 | $211K | — | Filing → |